Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis

References

• Forrest GN, Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev. 2010;23(1):14–34.
   PubMed Web of Science ®Google Scholar
• Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2009;49(7):1072–1079.
   PubMed Web of Science ®Google Scholar
• Tang HJ, Lai CC, Hsueh PR, et al. RNA polymerase B subunit gene mutations in biofilm-embedded methicillin-resistant Staphylococcus aureus following rifampin treatment. J Microbiol Immunol Infect. 2016;49(3):394–401.
   PubMedGoogle Scholar
• Russell CD, Lawson McLean A, Saunders C, Laurenson IF. Adjunctive rifampicin may improve outcomes in Staphylococcus aureus bacteraemia: a systematic review. J Med Microbiol. 2014;63(Pt 6):841–848.
   PubMedGoogle Scholar
• Sekiguchi J, Fujino T, Araake M, et al. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in TB wards. J Infect Chemother. 2006;12(1):47–50.
   PubMedGoogle Scholar
• Tan CK, Lai CC, Liao CH, et al. Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment. Int J Antimicrob Agents. 2011;37(6):550–553.
   PubMed Web of Science ®Google Scholar
• Septimus EJ, Schweizer ML. Decolonization in prevention of health care-associated infections. Clin Microbiol Rev. 2016;29(4):201–222.
   PubMedGoogle Scholar
• Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis. 2009;48(4):922–930.
   PubMedGoogle Scholar
• Falagas ME, Bliziotis IA, Fragoulis KN. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control. 2007;35(3):106–114.
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 27th Informational Supplement M100-S27. Wayne, PA: CLSI; 2018.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing. Clinical Breakpoints (version 8.0). EUCAST; 2018. Available from: http://www.eucast.orgclinical_breakpoints/. Accessed May 31, 2018.
   Google Scholar
• Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol. 1999;37(11):3556–3563.
   PubMed Web of Science ®Google Scholar
• Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38(3):1008–1015.
   PubMed Web of Science ®Google Scholar
• International Working Group on the Classification of Staphylococcal Cassette Chromosome Element (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother. 2009;53(12):4961–4967.
   PubMed Web of Science ®Google Scholar
• Huang YH, Tseng SP, Hu JM, et al. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect. 2007;13(7):717–724.
   PubMed Web of Science ®Google Scholar
• Wichelhaus TA, Schäfer V, Brade V, Böddinghaus B. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43(11):2813–2816.
   PubMed Web of Science ®Google Scholar
• Chen HJ, Hung WC, Tseng SP, et al. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother. 2010;54(12):4985–4991.
   PubMed Web of Science ®Google Scholar
• Didier JP, Villet R, Huggler E, et al. Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance. Antimicrob Agents Chemother. 2011;55(5):1946–1952.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. J Clin Microbiol. 2011;49(7):2680–2684.
   Google Scholar
• Baek KT, Thogersen L, Mogenssen RG, et al. Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene. Antimicrob Agents Chemother. 2015;59(11):6983–6991.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Lin MH, Shu JC, Lu JJ. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing. J Antimicrob Chemother. 2014;69(2):349–354.
   PubMed Web of Science ®Google Scholar
• Lee YT, Lin DB, Wang WY, et al. First identification of methicillin-resistant Staphylococcus aureus MLST types ST5 and ST45 and SCCmec types IV and Vt by multiplex PCR during an outbreak in a respiratory care ward in central Taiwan. Diagn Microbiol Infect Dis. 2011;70(2):175–182.
   PubMed Web of Science ®Google Scholar
• Ho CM, Lin CY, Ho MW, et al. Concomitant genotyping revealed diverse spreading between methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus in central Taiwan. J Microbiol Immunol Infect. 2016;49(6):363–370.
   PubMedGoogle Scholar
• Tsao FY, Kou HW, Huang YC. Dissemination of methicillin-resistant Staphylococcus aureus sequence type 45 among nursing home residents and staff in Taiwan. Clin Microbiol Infect. 2015;21(5):451–458.
   PubMed Web of Science ®Google Scholar